Person

Renshaw, Steve A.

Person ID
ZDB-PERS-050131-1
Email
s.a.renshaw@sheffield.ac.uk
URL
https://www.sheffield.ac.uk/iicd/profiles/renshaw
Affiliation
Renshaw Sheffield Lab
Address
Renshaw Laboratory, D39 Bateson Centre Firth Court Western Bank Sheffield, S10 2TN United Kingdom
Country
United Kingdom
Phone
+44 114 222 2334
Fax
+44 114 276 5413
ORCID ID
Biography and Research Interest
2018 marks my 20th year at the University of Sheffield. I am the Sir Arthur Hall Professor of Medicine and Director of the Bateson Centre - a large cross-faculty research centre (former MRC Centre, 41PIs, over 130 members and active grant funding of over £30m). I have important leadership roles in large cross-institution partnerships, including directing an MRC Doctoral Training Partnership across 4 major civic universities of the North of England – highly regarded as a model for student-led, cross-institutional, innovative postgraduate research training. I also have national and International leadership roles through membership of REF 2021 sub-panel 1, and through being a board member of Zebrafish Disease Models Society and principal organiser of Neutrophil 2020 – the foremost international neutrophil biology meeting. I studied medicine at Cambridge and then at Oxford Clinical School. After a clinical rotation in Nottingham, I moved to Sheffield to take up a Wellcome Trust Clinical Research Training Fellowship, to work on the regulation of neutrophil lifespan with Professor Moira Whyte. After 3 years as Clinical Lecturer in Respiratory Medicine, I was awarded an MRC Clinician Scientist Fellowship to develop an innovative model of neutrophil biology in the transparent, genetically tractable larval zebrafish. I have been able to develop a number of unique transgenic zebrafish which have allowed several important advances in our understanding of inflammation biology and of host-pathogen interaction. In 2008 I was awarded an MRC Senior Clinical Fellowship and in 2014 an MRC Programme Grant to continue this work. I continue clinical work in Respiratory Medicine with a special interest in Interstitial Lung Disease associated with a range of multisystem diseases.

Research Interests: Diseases of immunity cause much illness in the developed world – on one hand we are beset by a range of antibiotic resistance bacterial infections, while on the other hand our immune systems are responsible for many the common diseases of ageing – heart disease, stroke and COPD. Understanding the regulation of innate immune cells, neutrophils and macrophages, in infection and inflammation will help us tune the immune system to the exact level needed to cope with the current level of threat. More host defence to fight antibiotic resistant organisms; less host defence to prevent lung damage in response to environmental pollutants. To improve our understanding, I have set up a model system in which the genes controlling regulation of innate immune cell function can be identified. The model I have chosen is the Zebrafish, which is both genetically manipulable and transparent, leading to easy visualisation of immune cells during infection and inflammation. This model allows me to test the ability of a range of candidate genes to influence host-pathogen interaction and the resolution of inflammation, and additionally to screen for novel genes involved in this process. At the same time, I can see every immune cell during the whole of an infection or an inflammatory episode, where necessary imaging intracellular signalling events in real-time. The small size of our model also lends itself to drug screening and this has identified several potential new therapies for immune disease.
Publications
Non-Zebrafish Publications
1. Effective caspase inhibition blocks neutrophil apoptosis and reveals Mcl-1 as both a regulator and a target of neutrophil caspase activation. David J Wardle, Joseph Burgon, Ian Sabroe, Colin D Bingle, Moira KB Whyte, Stephen A Renshaw PLoS ONE 2011 6(1) e15768

2. Regulation of Neutrophil Senescence by MicroRNAs. Jon R. Ward, Paul R. Heath, Marta Milo, James W. Catto, Moira K.B. Whyte, Stephen A. Renshaw. PLoS ONE 2011 6(1) e15810

3. Dick EP, Prince LR, Prestwich EC, Renshaw SA, Whyte MK, Sabroe I. Pathways regulating lipopolysaccharide-induced neutrophil survival revealed by lentiviral transduction of primary human neutrophils. Immunology. 2008 Oct 28.

4. Identifying and hurdling obstacles to translational research. Ian Sabroe, David H. Dockrell, Stefanie N. Vogel, Stephen A. Renshaw, Moira K. B. Whyte and Steven K. Dower. Nature Reviews Immunology 2007, 2007; 7(1):77-82.

5. Granulocyte apoptosis in the pathogenesis and resolution of lung disease. Stephen M Bianchi, David H Dockrell, Stephen A Renshaw, Ian Sabroe, Moira KB Whyte. Clinical Science March 2006; 110(3):293-304

6. Expression of pro-apoptotic Bfk isoforms reduces during malignant transformation in the human gastrointestinal tract. Clare E. Dempsey, Caroline Dive, Daniel J. Fletcher, Frances A. Barnes, Alan Lobo, Colin D. Bingle, Moira K.B. Whyte, and Stephen A. Renshaw. FEBS Letters July 2005; 579 (17): 3646-3650

7. Three Novel Bid Proteins Generated By Alternative Splicing Of The Human Bid Gene. Stephen A. Renshaw, Clare E. Dempsey, Stephanie M. Bagstaff, Frances A. Barnes, Steven K. Dower, Colin D. Bingle, and Moira K.B. Whyte. Journal of Biological Chemistry Jan 2004; 279: 2846 - 2855.

8. Acceleration of Human Neutrophil Apoptosis by TRAIL. Stephen A. Renshaw, Jasvir S. Parmar, Vanessa Singleton, Sarah J. Rowe, David H. Dockrell, Steven K. Dower, Colin D. Bingle, Edwin R. Chilvers, and Moira K. B. Whyte Journal of Immunology 170 (2) January 2003 1027-1033.

9. Inflammatory neutrophils retain susceptibility to apoptosis mediated via the Fas death receptor. Stephen A. Renshaw, Samantha J. Timmons, Vanessa Eaton, Lynne R. Usher, Mohammed Akil, Colin D. Bingle, Moira K.B. Whyte. Journal of Leukocyte Biology 2000 67:662-668.

10. Apoptosis and the regulation of neutrophil lifespan. Moira K.B. Whyte, Stephen A. Renshaw, Roderick A. Lawson and Colin D. Bingle Biochemical Society Transactions 1999 27:802-807